Janey N. Parsons
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Signaling Pathways in Disease, Synthesis and biological activity, Protein Kinase Regulation and GTPase Signaling, RNA Interference and Gene Delivery
Most-Cited Works
- → The Activation State of p38 Mitogen-Activated Protein Kinase Determines the Efficiency of ATP Competition for Pyridinylimidazole Inhibitor Binding(1998)200 cited
- → Design and Synthesis of Potent, Selective, and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Mitogen-Activated Protein Kinase(1999)196 cited
- → Effect of corticosteroids on the human monocyte IgG and complement receptors.(1975)184 cited
- → Pyrroles and other heterocycles as inhibitors of P38 kinase(1998)117 cited
- → Analysis of IL-1 and TNF-alpha gene expression in human rheumatoid synoviocytes and normal monocytes by in situ hybridization.(1990)114 cited
- → Activation of JNK3α1 Requires both MKK4 and MKK7: Kinetic Characterization of in Vitro Phosphorylated JNK3α1(2000)80 cited
- → Chemical Genetics Define the Roles of p38α and p38β in Acute and Chronic Inflammation(2007)80 cited
- → Regulation of calcineurin phosphatase activity and interaction with the FK-506.FK-506 binding protein complex.(1994)63 cited
- → The Immunosuppressant FK-506 Specifically Inhibits Mitogen- Induced Activation of the Interleukin-2 Promoter and the Isolated Enhancer Elements NFIL-2A and NF-AT1(1991)39 cited
- → A TACROLIMUS-RELATED IMMUNOSUPPRESSANT WITH BIOCHEMICAL PROPERTIES DISTINCT FROM THOSE OF TACROLIMUS(1998)27 cited